News

Seniors with cancer respond just as well as younger patients to immune checkpoint inhibitors immunotherapy treatment.
Researchers in South Korea have proposed a novel cancer immunotherapy approach that could complement existing CAR-T (Chimeric ...
A new study led by scientists at the University of Oxford has revealed something surprising: a common virus carried by more ...
Moffitt Cancer Center launches new podcast, The ImmunoVerse, where Patrick Hwu, MD, will discuss immunotherapy research with ...
One of the best ways to defeat cancer is by rousing the immune system to attack it. Experts have thought that immune cells ...
Seniors with cancer respond just as well as younger patients to immune checkpoint inhibitors -- drugs that take the brakes ...
In a Q&A, Dr. Nataliya Uboha discussed how difficulty swallowing may signal esophageal cancer, treatment options and ongoing ...
Oncology experts discuss de-escalation strategies that can reduce toxicity, save a billion in healthcare costs, and make lung ...
Carl H. June, MD, the Richard W. Vague Professor in Immunotherapy in the Department of Pathology and Laboratory Medicine at ...
Immunai will generate a publicly accessible multi-omic dataset for a Parker Institute cohort of over 1,000 cancer patients.